0

Pimecrolimus

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP137071320
CAS137071-32-0
Structure
MDL NumberMFCD00901792
Molecular Weight810.45
InChI KeyKASDHRXLYQOAKZ-XDSKOBMDSA-N
Description≥97% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥97% (HPLC)
Colorwhite to beige
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

Efficacy and Safety of Tacrolimus Versus Pimecrolimus for the Treatment of Atopic Dermatitis in Children: A Network Meta-Analysis

Xia Huang, Bo Xu

Dermatology. 2015;231(1):41-9.

PMID: 26043855

1

Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic Disorders

Lyn Guenther, Charles Lynde, Yves Poulin

J Cutan Med Surg. Sep/Oct 2019;23(4_suppl):27S-34S.

PMID: 31476936

1

Off-label Uses of Topical Pimecrolimus

Matthew Ladda, Vijay Sandhu, Arvin Ighani, Jensen Yeung

J Cutan Med Surg. Jul/Aug 2019;23(4):442-448.

PMID: 31053034

1

Pimecrolimus in Atopic Dermatitis: Consensus on Safety and the Need to Allow Use in Infants

Thomas Luger, Mark Boguniewicz, Warner Carr, Michael Cork, Mette Deleuran, Lawrence Eichenfield, Philippe Eigenmann, Regina Fölster-Holst, Carlo Gelmetti, Harald Gollnick, Eckard Hamelmann, Adelaide A Hebert, etc.

Pediatr Allergy Immunol. 2015 Jun;26(4):306-15.

PMID: 25557211

1

Topical Calcineurin Inhibitors in the Treatment of Oral Lichen Planus: A Systematic Review and Meta-Analysis

S-L Sun, J-J Liu, B Zhong, J-K Wang, X Jin, H Xu, F-Y Yin, T-N Liu, Q-M Chen, X Zeng

Br J Dermatol. 2019 Dec;181(6):1166-1176.

PMID: 30903622

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode